Floatz logo

Viosterol

Secondary Hyperparathyroidism

Weill Medical College of Cornell UniversitySmall moleculePhase 4 / ApprovedDormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Secondary Hyperparathyroidism cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Viosterol is also rated in:

essential hypertensionDormant
B
Indicative · Phase 3
61 / 100
View asset →
impaired renal function diseaseDormant
B
Indicative · Phase 3
61 / 100
View asset →
vitamin D deficiencyActive
B
Indicative · Phase 4
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →